bluebird bio Statistics
Total Valuation
argenx SE has a market cap or net worth of $41.61 billion. The enterprise value is $38.08 billion.
Important Dates
The last earnings date was Thursday, July 31, 2025, before market open.
Earnings Date | Jul 31, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
argenx SE has 61.08 million shares outstanding. The number of shares has increased by 15.72% in one year.
Current Share Class | n/a |
Shares Outstanding | 61.08M |
Shares Change (YoY) | +15.72% |
Shares Change (QoQ) | -0.04% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 61.17M |
Valuation Ratios
The trailing PE ratio is 32.50.
PE Ratio | 32.50 |
Forward PE | n/a |
PS Ratio | 13.33 |
Forward PS | 10.26 |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | 29.74 |
EV / Sales | 12.20 |
EV / EBITDA | 83.42 |
EV / EBIT | 82.27 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 142.45 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | $1.95M |
Profits Per Employee | $800,749 |
Employee Count | 1,599 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -616.61M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +31.64% in the last 52 weeks. The beta is 0.03, so argenx SE's price volatility has been lower than the market average.
Beta (5Y) | 0.03 |
52-Week Price Change | +31.64% |
50-Day Moving Average | 570.84 |
200-Day Moving Average | 598.34 |
Relative Strength Index (RSI) | 81.93 |
Average Volume (20 Days) | 428,474 |
Short Selling Information
Short Interest | 1.80M |
Short Previous Month | 1.97M |
Short % of Shares Out | 3.25% |
Short % of Float | n/a |
Short Ratio (days to cover) | 3.95 |
Income Statement
In the last 12 months, argenx SE had revenue of $3.12 billion and earned $1.28 billion in profits. Earnings per share was $18.75.
Revenue | 3.12B |
Gross Profit | 1.63B |
Operating Income | 462.81M |
Pretax Income | -233.81M |
Net Income | 1.28B |
EBITDA | 456.47M |
EBIT | 462.81M |
Earnings Per Share (EPS) | $18.75 |
Full Income Statement Balance Sheet
Cash & Cash Equivalents | n/a |
Total Debt | n/a |
Net Cash | n/a |
Net Cash Per Share | n/a |
Equity (Book Value) | n/a |
Book Value Per Share | n/a |
Working Capital | n/a |
Full Balance Sheet Margins
Gross margin is 52.15%, with operating and profit margins of 14.83% and 41.03%.
Gross Margin | 52.15% |
Operating Margin | 14.83% |
Pretax Margin | 21.27% |
Profit Margin | 41.03% |
EBITDA Margin | 14.63% |
EBIT Margin | 14.83% |
FCF Margin | n/a |
Dividends & Yields
argenx SE does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -15.72% |
Shareholder Yield | -15.72% |
Earnings Yield | 3.08% |
FCF Yield | n/a |
Dividend Details Analyst Forecast
The average price target for argenx SE is $734.67, which is 9.60% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $734.67 |
Price Target Difference | 9.60% |
Analyst Consensus | Strong Buy |
Analyst Count | 17 |
Revenue Growth Forecast (5Y) | 30.38% |
EPS Growth Forecast (5Y) | 36.87% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |